Informace o publikaci
Efficacy Of Thalidomide-Based And Bortezomib-Based Regimens In The First Relapse Of 146 Multiple Myeloma Patients: A Single Centre Experience
| Název česky | Účinnosti léčebných režimů založených na thalidomidu a bortezomibu u 146 pacientů s mnohočetným myelomem s prvním relapsem: zkušenosti jednoho centra |
|---|---|
| Autoři | |
| Rok publikování | 2010 |
| Druh | Konferenční abstrakty |
| Fakulta / Pracoviště MU | |
| Citace | |
| Popis | The thalidomide-based and bortezomib-based regimens are effective in treatment of the first relapse MM with ORR 45-56%. Medians of TTP and OS are similar for both treatment groups, combination of novel agent with other drugs (dexamethason and/or alkylating agent) seems to be very useful. However, the significance part of patients (37-38%) had progression on this treatment and other treatment strategies are needed. |